Novartis AG (NVS)
97.28
+2.16
(+2.27%)
USD |
NYSE |
Apr 23, 16:00
97.24
-0.04
(-0.04%)
After-Hours: 20:00
Novartis Gross Profit (TTM): 36.60B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 36.60B |
September 30, 2023 | 35.77B |
June 30, 2023 | 34.71B |
March 31, 2023 | 34.44B |
December 31, 2022 | 34.13B |
September 30, 2022 | 30.98B |
June 30, 2022 | 32.50B |
March 31, 2022 | 32.54B |
December 31, 2021 | 32.24B |
September 30, 2021 | 36.28B |
June 30, 2021 | 35.63B |
March 31, 2021 | 34.45B |
December 31, 2020 | 34.78B |
September 30, 2020 | 34.69B |
June 30, 2020 | 34.61B |
March 31, 2020 | 35.03B |
December 31, 2019 | 34.25B |
September 30, 2019 | 33.39B |
June 30, 2019 | 32.60B |
March 31, 2019 | 32.08B |
December 31, 2018 | 31.59B |
September 30, 2018 | 29.22B |
June 30, 2018 | 29.66B |
March 31, 2018 | 29.80B |
December 31, 2017 | 29.77B |
Date | Value |
---|---|
September 30, 2017 | 32.40B |
June 30, 2017 | 32.01B |
March 31, 2017 | 32.00B |
December 31, 2016 | 31.92B |
September 30, 2016 | 32.05B |
June 30, 2016 | 32.18B |
March 31, 2016 | 32.36B |
December 31, 2015 | 32.98B |
September 30, 2015 | 33.67B |
June 30, 2015 | 34.45B |
March 31, 2015 | 35.61B |
December 31, 2014 | 36.29B |
September 30, 2014 | 36.55B |
June 30, 2014 | 36.45B |
March 31, 2014 | 36.07B |
December 31, 2013 | 36.77B |
September 30, 2013 | 34.85B |
June 30, 2013 | 35.54B |
March 31, 2013 | 36.28B |
December 31, 2012 | 36.10B |
September 30, 2012 | 38.70B |
June 30, 2012 | 39.48B |
March 31, 2012 | 40.06B |
December 31, 2011 | 40.39B |
September 30, 2011 | 40.45B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
30.98B
Minimum
Sep 2022
36.60B
Maximum
Dec 2023
34.19B
Average
34.45B
Median
Mar 2021
Gross Profit (TTM) Benchmarks
Sandoz Group AG | -- |
Roche Holding AG | 49.38B |
Amgen Inc | 19.74B |
Incyte Corp | 3.441B |
MorphoSys AG | 194.83M |